Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine in symptomatic Huntington's disease
2010-019444-39Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Huntington disease (HD) comparing Cysteamine bitartrate with Placebo (2 arms). Primary endpoint: Unified Huntington Disease Rating Scale motor score. Started May 2010; status: completed.
02
Drugs
cysteamine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2010-019444-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019444-39.